Simultaneous Determination of the Tuberculostatic Drugs Rifampicin, Isoniazid, and Pyrazinamide by CZE

被引:0
作者
Pontarolo, Roberto [1 ]
Graef, Lorena E. [1 ]
Campos, Francinete R. [1 ]
Fontana, Jose D. [1 ]
机构
[1] Univ Fed Parana, Dept Farm, UFPR, BR-80210170 Curitiba, Parana, Brazil
来源
LATIN AMERICAN JOURNAL OF PHARMACY | 2010年 / 29卷 / 08期
关键词
Capillary electrophoresis; Isoniazid; Pyrazinamide; Rifampicin; Tuberculosis; Validation; CAPILLARY-ELECTROPHORESIS; PHARMACEUTICAL FORMULATIONS; ANTITUBERCULAR DRUGS; COMBINATION; VALIDATION; PRODUCTS; ACID; BULK;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A simple and cost-effective method by capillary zone electrophoresis (CZE) was developed and validated for the simultaneous determination of the antituberculosis drugs isoniazid (INH), pyrazinamide (PYR), and rifampicin (RIF) in tablets. A 40 mmol L-1 sodium tetraborate background electrolyte (BGE) solution (pH 9.0) was found to be suitable for separation of all the analytes. An uncoated fused-silica capillary of 643 cm length (effective length 56 cm) was used for chromatography separation. All analytes were completely separated within 5 min at an applied voltage of 20 kV (max. 50 mu A), and detection was performed at 269.5 nm with an UV detector. The method was validated in terms of linearity, accuracy, precision, and robustness. The linearities of the calibration curves for INH, PYR, and RIF were 40-120 mu g/mL (r(2) = 0.9994), 20-100 mu g/mL (r(2) = 0.9997), and 40-100 mu g/mL (r(2) = 0.9999), respectively. The proposed method was successfully applied for the simultaneous determination of the tuberculostatic drugs RIF, INH, and PYR in tablets. Thus, the proposed CZE method is a potential alternative to the HPLC methods described by the US Pharmacopoeia for the quality control of tuberculostatic drugs.
引用
收藏
页码:1311 / 1318
页数:8
相关论文
共 50 条
  • [32] Simultaneous determination of rifampicin, isoniazid, pyrazinamide and ethambutol in 4-FDC tablet by Raman spectroscopy associated to chemometric approach
    Chellini, Paula R.
    Mendes, Thiago O.
    Franco, Pedro H. C.
    Porto, Brenda L. S.
    Tippavajhala, Vamshi K.
    Cesar, Isabela C.
    Oliveira, Marcone A. L.
    Pianetti, Gerson A.
    VIBRATIONAL SPECTROSCOPY, 2017, 90 : 14 - 20
  • [33] Bioavailability of rifampicin following concomitant administration of ethambutol or isoniazid or pyrazinamide or a combination of the three drugs
    Immanuel, C
    Gurumurthy, P
    Ramachandran, G
    Venkatesan, P
    Chandrasekaran, V
    Prabhakar, R
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2003, 118 : 109 - 114
  • [34] Development and Validation of an HPLC Method for Simultaneous Determination of Rifampicin, Isoniazid, Pyrazinamide, and Ethambutol Hydrochloride in Pharmaceutical Formulations
    Chellini, Paula R.
    Lages, Eduardo B.
    Franco, Pedro H. C.
    Nogueira, Fernando H. A.
    Cesar, Isabela C.
    Pianetti, Gerson A.
    JOURNAL OF AOAC INTERNATIONAL, 2015, 98 (05) : 1234 - 1239
  • [35] Estimation of Pyrazinamide, Isoniazid and Rifampicin in Pharmaceutical Formulations by High Performance Liquid Chromatography Method
    Gunasekaran, S.
    Sailatha, E.
    ASIAN JOURNAL OF CHEMISTRY, 2009, 21 (05) : 3561 - 3566
  • [36] Simultaneous polarographic determination of isoniazid and rifampicin by differential pulse polarography method and support vector regression
    Asadpour-Zeynali, Karim
    Soheili-Azad, Payam
    ELECTROCHIMICA ACTA, 2010, 55 (22) : 6570 - 6576
  • [37] Voltammetric method for the simultaneous determination of rifampicin and isoniazid in pharmaceutical formulations
    Wahdan, T
    CHEMIA ANALITYCZNA, 2005, 50 (02): : 457 - 464
  • [38] Simultaneous determination of isoniazid and p-aminosalicylic acid by capillary electrophoresis using chemiluminescence detection
    Zhang, Xinfeng
    Xuan, Yuelan
    Sun, Aimin
    Lv, Yi
    Hou, Xiandeng
    LUMINESCENCE, 2009, 24 (04) : 243 - 249
  • [39] Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis
    Gao, X-F.
    Wang, L.
    Liu, G-J.
    Wen, J.
    Sun, X.
    Xie, Y.
    Li, Y-P
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2006, 10 (10) : 1080 - 1090
  • [40] Bioequivalence assessment of rifampicin, isoniazid and pyrazinamide in a fixed dose combination of rifampicin, isoniazid, pyrazinamide and ethambutol vs. separate formulations
    Agrawal, S
    Singh, I
    Kaur, KJ
    Bhade, SR
    Kaul, CL
    Panchagnula, R
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2002, 40 (10) : 474 - 481